(MO) Altria - Ratings and Ratios
Cigarettes, Cigars, Smokeless, Nicotine-Pouches, E-Vapor
MO EPS (Earnings per Share)
MO Revenue
Description: MO Altria
Altria Group, Inc. (NYSE: MO) manufactures and sells a portfolio of combustible and oral tobacco products in the United States, including Marlboro cigarettes, Black & Mild cigars, Copenhagen and Skoal smokeless tobacco, the on! nicotine-pouch line, and NJOY ACE e-vapor devices. Distribution is handled through traditional wholesale channels and large-format retailers, with the company headquartered in Richmond, Virginia, and tracing its corporate lineage back to 1822.
Key quantitative signals (FY 2023) show a revenue of $27.1 billion, an adjusted earnings-per-share (EPS) of $6.31, and a dividend yield near 8 %-the latter reflecting Altria’s status as a high-yielding consumer-staples stock. The firm’s cash-flow conversion remains strong (≈ $5 billion free cash flow), supporting its $9 billion share-repurchase program. However, growth is constrained by declining smoking prevalence (U.S. adult smoking rate fell to 12.5 % in 2023, a 0.5 % YoY drop) and increasing regulatory pressure on nicotine-delivery products, which together create a secular headwind for the combustible segment.
Analysts typically model Altria’s earnings trajectory by weighting the stable, high-margin cigarette franchise (≈ 70 % of net sales) against the nascent, higher-growth “next-generation” product (NGP) segment, which has been expanding at roughly 15 % annual revenue CAGR since 2021 but still represents less than 10 % of total sales.
If you want a data-driven deep-dive into how Altria’s dividend sustainability, NGP rollout, and regulatory outlook compare to peers, a quick look at ValueRay’s analyst toolkit can provide the granular metrics you need to form a more informed view.
MO Stock Overview
Market Cap in USD | 109,277m |
Sub-Industry | Tobacco |
IPO / Inception | 1970-01-02 |
MO Stock Ratings
Growth Rating | 93.7% |
Fundamental | 72.0% |
Dividend Rating | 78.2% |
Return 12m vs S&P 500 | 19.8% |
Analyst Rating | 3.27 of 5 |
MO Dividends
Dividend Yield 12m | 6.46% |
Yield on Cost 5y | 15.60% |
Annual Growth 5y | 4.15% |
Payout Consistency | 98.1% |
Payout Ratio | 77.2% |
MO Growth Ratios
Growth Correlation 3m | 34.6% |
Growth Correlation 12m | 93.2% |
Growth Correlation 5y | 83.8% |
CAGR 5y | 21.27% |
CAGR/Max DD 3y (Calmar Ratio) | 1.49 |
CAGR/Mean DD 3y (Pain Ratio) | 5.30 |
Sharpe Ratio 12m | 1.10 |
Alpha | 26.17 |
Beta | 0.572 |
Volatility | 19.46% |
Current Volume | 9162.4k |
Average Volume 20d | 6965.1k |
Stop Loss | 61.8 (-3.1%) |
Signal | -0.23 |
Piotroski VR‑10 (Strict, 0-10) 7.0
Net Income (8.79b TTM) > 0 and > 6% of Revenue (6% = 1.22b TTM) |
FCFTA 0.33 (>2.0%) and ΔFCFTA 7.53pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
NWC/Revenue -20.51% (prev -20.90%; Δ 0.39pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
CFO/TA 0.34 (>3.0%) and CFO 10.88b > Net Income 8.79b (YES >=105%, WARN >=100%) |
Net Debt (23.43b) to EBITDA (12.00b) ratio: 1.95 <= 3.0 (WARN <= 3.5) |
Current Ratio 0.39 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
Outstanding Shares last Quarter (1.68b) change vs 12m ago -1.98% (target <= -2.0% for YES) |
Gross Margin 71.63% (prev 69.53%; Δ 2.09pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
Asset Turnover 60.73% (prev 59.02%; Δ 1.71pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
Interest Coverage Ratio 11.10 (EBITDA TTM 12.00b / Interest Expense TTM 1.06b) >= 6 (WARN >= 3) |
Altman Z'' 6.10
(A) -0.13 = (Total Current Assets 2.63b - Total Current Liabilities 6.79b) / Total Assets 32.33b |
(B) 1.10 = Retained Earnings (Balance) 35.52b / Total Assets 32.33b |
warn (B) unusual magnitude: 1.10 — check mapping/units |
(C) 0.35 = EBIT TTM 11.75b / Avg Total Assets 33.36b |
(D) 0.95 = Book Value of Equity 33.63b / Total Liabilities 35.54b |
Total Rating: 6.10 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 71.98
1. Piotroski 7.0pt = 2.0 |
2. FCF Yield 8.09% = 4.04 |
3. FCF Margin 52.97% = 7.50 |
4. Debt/Equity -7.59 = -2.50 |
5. Debt/Ebitda 1.95 = 0.09 |
6. ROIC - WACC (= 33.78)% = 12.50 |
7. RoE -281.8% = -2.50 |
8. Rev. Trend -20.56% = -1.54 |
9. EPS Trend 47.69% = 2.38 |
What is the price of MO shares?
Over the past week, the price has changed by -2.52%, over one month by -0.06%, over three months by +9.95% and over the past year by +39.41%.
Is Altria a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MO is around 74.49 USD . This means that MO is currently undervalued and has a potential upside of +16.85% (Margin of Safety).
Is MO a buy, sell or hold?
- Strong Buy: 3
- Buy: 1
- Hold: 9
- Sell: 1
- Strong Sell: 1
What are the forecasts/targets for the MO price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 63.8 | 0.1% |
Analysts Target Price | 63.8 | 0.1% |
ValueRay Target Price | 81.8 | 28.3% |
Last update: 2025-10-18 05:03
MO Fundamental Data Overview
P/E Trailing = 12.5822
P/E Forward = 11.7371
P/S = 5.394
P/B = 27.3016
P/EG = 4.0147
Beta = 0.572
Revenue TTM = 20.26b USD
EBIT TTM = 11.75b USD
EBITDA TTM = 12.00b USD
Long Term Debt = 23.65b USD (from longTermDebt, last quarter)
Short Term Debt = 1.07b USD (from shortTermDebt, last quarter)
Debt = 24.72b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 23.43b USD (from netDebt column, last quarter)
Enterprise Value = 132.71b USD (109.28b + Debt 24.72b - CCE 1.29b)
Interest Coverage Ratio = 11.10 (Ebit TTM 11.75b / Interest Expense TTM 1.06b)
FCF Yield = 8.09% (FCF TTM 10.73b / Enterprise Value 132.71b)
FCF Margin = 52.97% (FCF TTM 10.73b / Revenue TTM 20.26b)
Net Margin = 43.37% (Net Income TTM 8.79b / Revenue TTM 20.26b)
Gross Margin = 71.63% ((Revenue TTM 20.26b - Cost of Revenue TTM 5.75b) / Revenue TTM)
Gross Margin QoQ = 72.78% (prev 71.90%)
Tobins Q-Ratio = 4.10 (Enterprise Value 132.71b / Total Assets 32.33b)
Interest Expense / Debt = 1.11% (Interest Expense 275.0m / Debt 24.72b)
Taxrate = 23.73% (740.0m / 3.12b)
NOPAT = 8.96b (EBIT 11.75b * (1 - 23.73%))
Current Ratio = 0.39 (Total Current Assets 2.63b / Total Current Liabilities 6.79b)
Debt / Equity = -7.59 (negative equity) (Debt 24.72b / totalStockholderEquity, last quarter -3.26b)
Debt / EBITDA = 1.95 (Net Debt 23.43b / EBITDA 12.00b)
Debt / FCF = 2.18 (Net Debt 23.43b / FCF TTM 10.73b)
Total Stockholder Equity = -3.12b (last 4 quarters mean from totalStockholderEquity)
RoA = 27.18% (Net Income 8.79b / Total Assets 32.33b)
RoE = -281.8% (negative equity) (Net Income TTM 8.79b / Total Stockholder Equity -3.12b)
RoCE = 57.22% (EBIT 11.75b / Capital Employed (Equity -3.12b + L.T.Debt 23.65b))
RoIC = 40.55% (NOPAT 8.96b / Invested Capital 22.10b)
WACC = 6.78% (E(109.28b)/V(134.00b) * Re(8.12%) + D(24.72b)/V(134.00b) * Rd(1.11%) * (1-Tc(0.24)))
Discount Rate = 8.12% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.41%
[DCF Debug] Terminal Value 78.29% ; FCFE base≈9.97b ; Y1≈10.14b ; Y5≈11.14b
Fair Price DCF = 115.4 (DCF Value 193.83b / Shares Outstanding 1.68b; 5y FCF grow 1.52% → 3.0% )
EPS Correlation: 47.69 | EPS CAGR: 4.38% | SUE: 2.74 | # QB: 2
Revenue Correlation: -20.56 | Revenue CAGR: -0.83% | SUE: 0.07 | # QB: 0
Additional Sources for MO Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle